CFTR and cystic fibrosis: Here, we explored the effects of the MCG1516A compound alone or in combination with the FDA-approved corrector drug VX-661 in CF bronchial epithelial (CFBE) cell lines constitutively expressing WT-CFTR or F508del-CFTR.